Culture

Farm-level study shows rising temperatures hurt rice yields

A study of the relationship between temperature and yields of various rice varieties, based on 50 years of weather and rice-yield data from farms in the Philippines, suggests that warming temperatures negatively affect rice yields.

Recent varieties of rice, bred for environmental stresses like heat, showed better yields than both traditional rice varieties and modern varieties of rice that were not specifically bred to withstand warmer temperatures. But the study found that warming adversely affected crop yields even for those varieties best suited to the heat. Overall, the advantage of varieties bred to withstand increased heat was too small to be statistically significant.

One of the top 10 countries globally in rice production, the Philippines is also a top-10 rice importer, as domestic supply cannot meet demand.

Roderick Rejesus, a professor and extension specialist of agricultural and resource economics at North Carolina State University and the corresponding author of a paper that describes the study, says that teasing out the effects of temperature on rice yields is important to understand whether rice-breeding efforts have helped address the environmental challenges faced by modern society, such as global warming.

The study examined rice yields and atmospheric conditions from 1966 to 2016 in Central Luzon, the major rice-growing region of the Philippines. Rejesus and study colleagues were able to utilize farm-level data of rice yields and area weather conditions in four-to-five-year increments over the 50-year period, a rare data trove that allowed the researchers to painstakingly examine the relationship between rice yield and temperature in actual farm environments.

"This rich data set allowed us to see what was actually happening at the farm level, rather than only observing behavior at higher levels of aggregation like in provinces or districts," Rejesus said.

The study examined three general rice varieties planted during those 50 years: traditional rice varieties; "early modern varieties" planted after the onset of the Green Revolution, which were bred for higher yields; and "recent modern varieties" bred for particular characteristics, like heat or pest resistance, for example.

Perhaps as expected, the study showed that, in the presence of warming, recent modern varieties had the best yields when compared with the early modern and traditional varieties, and that early modern varieties outperformed traditional varieties. Interestingly, some of the early modern varieties may have also mitigated heat challenges given their smaller "semi-dwarf" plant architecture, even though they were not bred to specifically resist heat.

"Taken all together, there are two main implications here," Rejesus said. "The first is that, at the farm level, there appears to be a 'yield gap' between how rice performs in breeding trials and on farms, with farm performance of recent varieties bred to be more tolerant to environmental stresses not being statistically different relative to the older varieties.

"The second is that rice breeding efforts may not have reached their full potential such that it may be possible to produce new varieties that will statistically perform better than older varieties in a farm setting."

Rejesus also acknowledged that the study's modest sample size may have contributed to the inability to find statistical significance in the differences in warming impacts between rice varietal yields.

"This paper has implications for other rice-breeding countries, like Vietnam, because the timing of the release of various rice varieties is somewhat similar to that of the Philippines," Rejesus said. "Plant-breeding institutions can learn from this type of analysis, too. It provides guidance as to where research funding may be allocated by policymakers to further improve the high temperature tolerance of rice varieties available to farmers."

Rejesus plans to further study other agricultural practices and innovations that affect crop yields, including an examination of cover crops, or plants grown on cropland in the off season that aim to keep soils healthy, to gauge whether they can mitigate the adverse impacts of a changing climate.

Credit: 
North Carolina State University

Children's preventive healthcare costs dropped under ACA: BU study

The Affordable Care Act (ACA) dramatically increased children's preventive healthcare while reducing out-of-pocket costs, according to a new Boston University School of Public Health (BUSPH) study.

Published in JAMA Network Open, the study found that checkups with out-of-pocket costs dropped from 54.2% of visits in 2010 (the year the ACA passed) to 14.5% in 2018.

"This is a great feather in the cap of the ACA, even though there is still some work to do," says study lead author Dr. Paul Shafer, assistant professor of health law, policy & management at BUSPH.

"We found that one in seven families were still charged something for their children's well visits," he says, "and costs can be a barrier to parents keeping their kids up-to-date with preventive care."

Shafer and colleagues analyzed national health insurance claims data from 2006 through 2018 for children 0 to 17 years old.

Even before the ACA became law in 2010, the researchers saw improving trends in preventive pediatric care. The proportion of children who went to the doctor at least once per year without having a preventive checkup dropped from 39.3% in 2006 to 29.0% in 2018. The researchers also found a 60% increase in the proportion of so-called "sick" visits (for anything other than a checkup) that included one or more preventive services, such as immunizations or recommended screenings. The researchers write that this may mean pediatricians are increasingly taking advantage of any opportunity they can to provide preventive care.

"As deductibles and copays continue to rise, the promise of free preventive care has become a very popular benefit of the ACA," Shafer says. "According to our results, we are continuing to get better at delivering on that promise for children."

Credit: 
Boston University School of Medicine

Study provides insights into architecture of abnormal protein deposits in brain disorders

CLEVELAND--Scientists at the Case Western Reserve University School of Medicine have determined the structure of protein "fibrils" linked to Lou Gehrig's disease and other neurodegenerative disorders--findings that provide clues to how toxic proteins clump and spread between nerve cells in the brain.

Their results may also lead to developing drugs to treat diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

"These devastating brain disorders that affect tens of thousands of Americans?are on the rise worldwide, and there are no effective treatments to stop their progression," said Witold Surewicz, a professor in the Department of Physiology and Biophysics at the School of Medicine and the study's senior author.

The study was published March 12 in the online journal Nature Communications. Qiuye Li, a graduate student in the department, was lead author; Case Western Reserve medical student Michael Babinchak contributed.

The study was supported by the National Institutes of Health.

TDP-43 is normally a soluble protein that interacts with nucleic acids. However, in several neurodegenerative disorders, this protein forms large, harmful rope-like clumps that accumulate in brains of afflicted patients.

These abnormal structures, known as amyloid fibrils, are a signature of brain pathology in amyotrophic lateral sclerosis (ALS; also called Lou Gehrig's disease) and FTD, the most common cause of dementia in people at younger ages--in their 50s and 60s.

Similar fibrilar structures of TDP-43 are also linked to other brain disorders, including Alzheimer's disease and chronic traumatic encephalopathy, a condition caused by repeated brain injuries and often found in athletes who played football and other contact sports.

By using a technique of electron microscopy at very low temperature (cryo-electron microscopy), the authors analyzed thousands of images of fibrils formed in the test tube by the key fragment of TDP-43. They determined the complex architecture of these elongated structure at a resolution close to individual atoms. This structural insight revealed, among other findings, the nature of the template on which more copies of TDP-43 can lock.

Based on this structural model, the researchers also discussed how the fibril structure could be controlled by amino acid mutations in TDP-43 linked to hereditary forms of ALS and FTD, as well as by aging-dependent modifications of the protein.

"This is really an exciting development because it reveals a mechanism for the growth of these toxic aggregates," Li said.

"This, in turn, provides important clues as to how these aggregates may spread between the cells in affected brains."

"Detailed knowledge about fibrillar structures formed by TDP-43 may also lead to the development of drugs to treat these devastating brain disorders," Surewicz said.

Credit: 
Case Western Reserve University

Accurate aging of wild animals thanks to first epigenetic clock for bats

image: UMD-led study revealed age-related changes to the DNA of bats related to longevity. Clockwise from top left: common vampire bat (G. Wilkinson), greater horseshoe bat (G. Jones), velvety free-tailed bat (M. Tschapka) and greater mouse-eared bat (S. Puechmaille). All can live 30 years or longer except velvety free-tailed bat, which only lives to 6 years of age.

Image: 
G. Wilkinson, G. Jones, S. Puechmaille, M. Tschapka

A new study led by University of Maryland and UCLA researchers found that DNA from tissue samples can be used to accurately predict the age of bats in the wild. The study also showed age-related changes to the DNA of long-lived species are different from those in short-lived species, especially in regions of the genome near genes associated with cancer and immunity. This work provides new insight into causes of age-related declines.

This is the first research paper to show that animals in the wild can be accurately aged using an epigenetic clock, which predicts age based on specific changes to DNA. This work provides a new tool for biologists studying animals in the wild. In addition, the results provide insight into possible mechanisms behind the exceptional longevity of many bat species. The study appears in the March 12, 2021, issue of the journal Nature Communications.

"We hoped that these epigenetic changes would be predictive of age," said Gerald Wilkinson, a professor of biology at UMD and co-lead author of the paper. "But now we have the data to show that instead of having to follow animals over their lifetime to be sure of their age, you can just go out and take a tiny sample of an individual in the wild and be able to know its age, which allows us to ask all kinds of questions we couldn't before."

The researchers looked at DNA from 712 bats of known age, representing 26 species, to find changes in DNA methylation at sites in the genome known to be associated with aging. DNA methylation is a process that switches genes off. It occurs throughout development and is an important regulator for cells. Overall, methylation tends to decrease throughout the genome with age. Using machine learning to find patterns in the data, the researchers found that they could estimate a bat's age to within a year based on changes in methylation at 160 sites in the genome. The data also revealed that very long-lived bat species exhibit less change in methylation overall as they age than shorter-lived bats.

Wilkinson and his team then analyzed the genomes of four bat species--three long-lived and one short-lived--to identify the specific genes present in those regions of the genome where age-related differences in methylation correlated with longevity. They found specific sites on the genome where methylation was more likely to increase rather than decrease with age in the short-lived bats, but not in long-lived bats, and that those sites were located near 57 genes that mutate frequently in cancerous tumors and 195 genes involved in immunity.

"What's really interesting is that the sites where we found methylation increasing with age in the short-lived bats are near genes that have been shown to be involved in tumorigenesis--cancer--and immune response," Wilkinson said. "This suggests there may be something to look at in these regions regarding mechanisms responsible for longevity."

Wilkinson said analyzing methylation may provide insight into many age-related differences between species and lead to a better understanding of the causes for age-related declines across many species.

"Bats live a long time, and yet their hearing doesn't decay with age, the way ours does," he said. "You could use this method to see whether there are differences in methylation that are associated with hearing. There are all kinds of questions like this we can ask now."

Credit: 
University of Maryland

Heart attack diagnosis missed in women more often than in men

Chest pain is misdiagnosed in women more frequently than in men, according to research presented today at ESC Acute CardioVascular Care 2021, an online scientific congress of the European Society of Cardiology (ESC).1 The study also found that women with chest pain were more likely than men to wait over 12 hours before seeking medical help.

"Our findings suggest a gender gap in the first evaluation of chest pain, with the likelihood of heart attack being underestimated in women," said study author Dr. Gemma Martinez-Nadal of the Hospital Clinic of Barcelona, Spain. "The low suspicion of heart attack occurs in both women themselves and in physicians, leading to higher risks of late diagnosis and misdiagnosis."

This study examined gender differences in the presentation, diagnosis, and management of patients admitted with chest pain to the chest pain unit of an emergency department between 2008 and 2019. Information was collected on risk factors for a heart attack including high blood pressure and obesity. The researchers recorded the physician's initial diagnosis after the first evaluation of each patient, which is based on clinical history, physical examination, and an electrocardiogram (ECG) and occurs before other examinations like blood tests.

"We had the first impression of the doctor as to whether the chest pain had a coronary cause or another origin such as anxiety or a musculoskeletal complaint," explained Dr. Martinez-Nadal.

A total of 41,828 patients with chest pain were included, of which 42% were women. The median age was 65 years in women and 59 years in men. Women were significantly more likely to present late to the hospital (defined as waiting 12 hours or longer after symptom onset): this occurred in 41% of women compared to 37% of men.

"This is worrying since chest pain is the main symptom of reduced blood flow to the heart (ischaemia) because an artery has narrowed," said Dr. Martinez-Nadal. "It can lead to a myocardial infarction which needs rapid treatment."

In the physician's initial diagnosis, acute coronary syndrome was more likely to be considered the cause of chest pain in men compared to women. Specifically, in 93% of patients, the ECG did not provide a definitive diagnosis. In those patients, the doctor noted a probable acute coronary syndrome (ACS) in 42% of cases - when analysed according to gender, probable ACS was noted in 39% of women and 44.5% of men (p

Dr. Martinez-Nadal said: "In the doctor's first impression, women were more likely than men to be suspected of a non-ischaemic problem. Risk factors like hypertension and smoking should instil a higher suspicion of possible ischaemia in patients with chest pain. But we observed that women with risk factors were still less likely than men to be classified as 'probable ischaemia'."

In women, 5% of ACS were initially misdiagnosed, whereas in men, 3% of ACS were initially misdiagnosed (p

Dr. Martinez-Nadal said: "Heart attack has traditionally been considered a male disease, and has been understudied, underdiagnosed, and undertreated in women, who may attribute symptoms to stress or anxiety. Both women and men with chest pain should seek medical help urgently."

Credit: 
European Society of Cardiology

Otago discovers treatment for type-2 diabetic heart disease

University of Otago researchers have discovered one of the reasons why more than 50 per cent of people with type 2 diabetes die from heart disease.

And perhaps more significantly, they have found how to treat it.

Associate Professor Rajesh Katare, of the Department of Physiology, says it has been known that stem cells in the heart of diabetic patients are impaired. While stem cell therapy has proved effective in treating heart disease, it is not the case in diabetic hearts.

It has not been known why; until now.

It comes down to tiny molecules called microRNA which control gene expression.

"Based on the results of laboratory testing, we identified the number of microRNAs that are impaired in stem cells of the diabetic heart," Associate Professor Katare says.

"Among several microRNAs we identified that one particular microRNA called miR-30c - which is crucial for the stem cells' survival, growth and new blood vessel formation - is reduced in the diabetic stem cells. All these functions are required for stem cell therapy to be successful in the heart.

"Importantly, we also confirmed that this microRNA is decreased in the stem cells collected from the heart tissue of the patients undergoing heart surgery at Dunedin Hospital."

Researchers were able to then increase the level of the lacking miR-30c in the heart by a "simple injection".

"This resulted in significantly improving the survival and growth of stem cells in the diabetic heart," Associate Professor Katare says.

"This fascinating discovery has newly identified that impairment in the microRNAs is the underlying reason for the stem cells being not functional in the diabetic heart. More importantly, the results have identified a novel therapy for activation of stem cells in the heart using microRNA, without the need to inject stem cells, which is a time and cost consuming process."

Associate Professor Katare calls the finding "significant" and says it could help diabetes- sufferers - who are ten per cent of New Zealanders - lead a longer, quality life.

"Apart from identifying the reasons for poor stem cells function in a patient with diabetes, the novel therapy of using microRNA could change the treatment method for heart disease in diabetic individuals."

Researchers will now undertake more laboratory testing before moving on to humans.

"Our initial analysis revealed that there might be another four potential candidate microRNAs. Therefore, it is essential to test the function of those microRNAs as well. It may be possible that combination therapy with more than one microRNA could further increase the beneficial effects."

Credit: 
University of Otago

Lifestyle research studies to reduce risk of Alzheimer's respond to COVID-19 challenges

The impact of the COVID-19 pandemic on public health is staggering; more than one hundred million cases and two million deaths worldwide. In response, most countries and local governments have taken substantial measures -- such as travel restrictions and physical distancing -- to keep their citizens safe. Both the pandemic and related protective measures pose challenges for ongoing clinical research studies seeking to treat and prevent the world's greatest public health emergencies including COVID-19, but also Alzheimer's disease and other dementia.

In a new paper from the World-Wide FINGERS network in Alzheimer's & Dementia: Translational Research and Clinical Interventions, first author Susanne Röhr, Ph.D., clinical psychologist at the Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Germany, and colleagues provide timely guidance on the design and management of clinical research during COVID-19 -- specifically on the conduct of lifestyle-based risk reduction studies in people at risk for cognitive decline and dementia.

The article describes the COVID-19-related experiences of three trials - each at a different stage of the study process - conducted in conjunction with the World-Wide FINGERS (WW-FINGERS), the first global network of lifestyle-based multidomain trials for dementia risk reduction and prevention, which includes over 30 countries.

J-MINT: Japan-multimodal intervention trial for prevention of dementia -- mainly in the recruitment process (~December, 2020) and intervention delivery.

U.S. POINTER: U.S. study to protect brain health through a lifestyle intervention to reduce risk -- recruitment process and intervention delivery.

German AgeWell.de study -- intervention adherence and post-intervention follow-up.

"The COVID-19 pandemic has profoundly altered the landscape for the design and conduct of clinical trials of multidomain lifestyle interventions. This is especially true in studies focused on cognition, Alzheimer's and other dementia, where the study population has some of the greatest health risks," said Röhr, who also is an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute.

"With this collaborative publication, we bring together and discuss our experiences of the challenges we've faced, and continue to face, and how we've responded to them. By sharing our collective knowledge about the lessons learned so far, we can provide real-world, evidence-based recommendations to similar ongoing and prospective lifestyle intervention trials," Rohr added.

In response to COVID-19, the WW-FINGERS network created a shared space for its members to discuss the challenges of research during the pandemic. They gathered international teams with expertise to address, almost in real-time, the challenges that cut across the research. This allows studies at earlier stages to adjust to these potential challenges, while more advanced studies will still be able to access expertise to adapt to their specific circumstances.

"By working together, we can address and solve common problems and find effective strategies to prevent cognitive decline and Alzheimer's disease," said Mark Espeland, Ph.D., professor of Internal Medicine at Wake Forest School of Medicine and senior author on the newly published article.

"The WW-FINGERS collaborative efforts are needed more than ever in the current landscape. The network's joint knowledge and expertise is shaping lifestyle interventions both during and in the post-pandemic scenario," said Miia Kivipelto, M.D., Ph.D., professor of Clinical Geriatrics at Karolinska Institute, founder and scientific leader of the WW-FINGERS network and co-author of the article.

"Looking at the impact of COVID-19 across the WW-FINGERS network of clinical trials enables us to evaluate the effectiveness of our responses to the pandemic across different cultures, local environments, and phases of the pandemic," said Maria C. Carrillo, Ph.D., Alzheimer's Association chief science officer and a co-author of the article. "The lessons learned through WW-FINGERS might be helpful for other lifestyle intervention research as well."

"Conducting a clinical trial such as J-MINT is a huge challenge during the pandemic, but we have learned a lot about how to prevent the infection. Applying this knowledge to this and other clinical trials should be useful for improving future implementation of lifestyle-based dementia prevention measures," said Hidenori Arai, M.D., Ph.D., President, National Center for Geriatrics and Gerontology, and co-author of the newly published article.

Lifestyle intervention research may be particularly susceptible to disruption from the pandemic. Traditionally, lifestyle interventions focus on strong bonds through group and individual face-to-face sessions. Social isolation -- which can result from physical distancing -- can also challenge lifestyle interventions. Research studies focused on preventing cognitive decline often recruit individuals for whom COVID-19 poses greater risks due to their older age and greater burden of age-related noncommunicable diseases.

Each of the four WW-FINGERS studies adapted by altering designs and analysis plans -- changing recruitment plans, timelines, and modes of delivery for interventions and assessments. For example:

Due to the COVID-19 pandemic, J-MINT was forced to halt recruitment and initial evaluation of participants from late February to mid-May 2020. Enrollment activities resumed in late May 2020 with appropriate measures to defend against infection. To help ensure safety of participants and study staff, new rules and procedures for testing and intervention were implemented. This added extra time and cost. As a result, progress of the study was delayed more than half a year. Nonetheless, by December 2020, planned recruitment was completed. The potential statistical problem caused by the four-month gap on average from the initial evaluation to the intervention will be addressed through additional analysis to see if this is correlated with the magnitude of cognitive changes. If the time between the initial evaluation and the start of the intervention is longer than 6 months, the team will conduct a reevaluation and may conduct a sub-analysis that excludes the study participants who were reevaluated.

During a study-wide pause from March to July 2020, U.S. POINTER researchers maintained contact with study participants through phone calls that encouraged participants to continue to meet their study intervention goals. Intervention delivery shifted from in-person meetings to video conferencing. Some data were accumulated continuously during the pause, but others were postponed and rescheduled. Following the pause, intervention meetings were held remotely and full adherence monitoring was resumed.

In Germany, infection control measures, including the first nationwide lockdown, largely coincided with AgeWell.de's intervention period. As the quarantine measures put restrictions on lifestyles, concerns specifically arose regarding social and physical activity and mental wellbeing. In addition, face-to-face post-intervention assessments were at risk; and changing the assessment mode would violate the data integrity. Therefore, a safety and hygiene protocol was developed, including an option to be interviewed at the study site instead of at home. To better understand the pandemic impact, the researchers mailed a survey to participants during the first lockdown to measure changes to everyday life, social and mental health and resilience. The survey will be repeated to gain a longitudinal perspective of the pandemic impact.

Credit: 
Alzheimer's Association

Firefly tourism takes flight, sparking wonder and concern

image: In North Carolina USA, male blue ghost fireflies (Phausis reticulata) glow while searching for mates. Their flightless females are highly vulnerable to trampling, as they remain hidden on the forest floor

Image: 
Spencer Black

Firefly beetles rank among the world's most charismatic creatures, with luminous courtship displays that have now turned them into a popular attraction for wildlife tourists. In the first comprehensive review of firefly tourism, published in the journal Conservation Science and Practice, an international team of biologists led by a Tufts University researcher, reveal that an estimated 1 million people now travel each year to witness bioluminescent performances starring some two dozen firefly species around the world.

But the authors also point out that while this unique, insect-based tourism can bring economic, social, and psychological benefits to local communities and tourists alike, it also threatens to extinguish some local firefly populations unless adequate protections are put in place.

"With this review of the current state of firefly tourism and the declining health of their habitats, we are putting out a call to action to engage local communities and governments, as well as the tourists themselves, to act as guardians of the fireflies," said lead author Sara Lewis, professor of biology at Tufts University and co-chair of the International Union for the Conservation of Nature's (IUCN) Firefly Specialist Group, which conducted the review. The IUCN firefly group works to identify key threats and conservation issues facing fireflies in different geographic regions, and advocates for the most threatened species at national and global levels. Lewis' earlier work on fireflies with the IUCN has drawn considerable attention and fascination among the public and other researchers, with media coverage including CNN and The Washington Post.

In recent years, the number of tourists has skyrocketed at several sites in Mexico, India, Taiwan, Malaysia, Thailand, and the United States. "In Mexico, the rapid growth of firefly tourism over the past decade is thrilling but also alarming," said Tania López-Palafox, graduate student at Universidad Nacional Autónoma de México and co-author of the review. "The COVID pandemic gave them a momentary respite, but we have witnessed the harm that too much tourism can do."

Aimed at site managers, tour guides, and tourists, the report highlights the need to recognize ecological requirements across all firefly life stages. To promote the breeding success of firefly adults, sites should minimize light pollution: bright lights from buildings, vehicles, flashlights, and even cell phones - all of which can disrupt firefly courtship rituals.

Protection of nearby habitats also plays an essential role. Fireflies spend most of their life cycle in a juvenile, larval stage. These juveniles require several months or even years to develop into their adult form and, depending on the species, spend this time living below ground, in leaf litter or sometimes underwater. The authors describe former firefly sites along mangrove rivers where commercial development and excessive motorboat traffic have degraded riverbank habitat that had been essential for supporting firefly larvae.

At some sites, the reproductive cycle of firefly populations is threatened by tourists inadvertently trampling female fireflies and degrading larval habitats. Females in many species can't fly, and so are particularly susceptible to tourist foot traffic. Learn more about the mating rituals of fireflies studied by the Tufts research team in this video.

The report noted the popularity of displays created by several kinds of synchronous fireflies found in Southeast Asia and North America, where hundreds or thousands of firefly males captivate females - and tourists, too - by flashing their lights together in unison. According to co-author Anchana Thancharoen, lecturer at Kasetsart University in Bangkok, "With such mesmerizing lights, the firefly display trees make tourists fall in love at first sight. Our aim with this call to action is to channel that love into support for conservation efforts."

Credit: 
Tufts University

Mindfulness meditation improves quality of life in heart attack survivors

An eight-week programme of mindfulness meditation improves quality of life and reduces fear of activity in heart attack patients, according to research presented today at ESC Acute CardioVascular Care 2021, an online scientific congress of the European Society of Cardiology (ESC).1

"A heart attack is a serious life-threatening event and survivors can suffer from low quality of life," said study author Dr. Canan Karadas of Hacettepe University, Ankara, Turkey. "One reason is a fear of movement, called kinesiophobia, which limits daily activity due to concerns of another heart attack."

"Mindfulness refers to the mental state achieved by focusing awareness on the present moment, including thoughts, feelings, and physical sensations," continued Dr. Karadas. "It has drawn increasing attention for treating chronic conditions such as high blood pressure. Our study examined its effect on fatigue, kinesiophobia, and quality of life after an acute myocardial infarction."

The study included 56 patients who had experienced a heart attack. The average age at enrolment was 55 years. Participants were randomly assigned to a mindfulness or control group for eight weeks. Patients in the control group attended one 15-minute individual education session on the structure and function of the heart, the coronary arteries, and diseases of the heart.

Patients assigned to the mindfulness intervention attended an individual session which included a 15-minute description of the technique. This was followed by 15 minutes of supervised practice: patients were asked to sit comfortably on a chair with their backs straight and eyes closed. They were then instructed to breathe deeply - inhaling through the nose and exhaling through the mouth using the diaphragm - and focus on their breathing and the present moment. Participants received a recording of the instructions via WhatsApp and were asked to repeat the 15-minute session every day at home in a quiet room. Daily reminders (text messages or phone calls) were used to motivate patients to practice the meditation and to evaluate their compliance with the study protocol.

Fatigue, kinesiophobia, and quality of life were assessed at baseline and weeks four, eight and 12 using the Piper Fatigue Scale, Tampa Scale for Kinesiophobia Heart questionnaire, and MacNew Heart Disease Health-Related Quality of Life questionnaire which examines patients' feelings about how their heart condition affects daily function overall and in three areas (physically, emotionally, and socially).

At baseline, there were no differences in the three variables between the intervention and control groups. By week four, patients in the mindfulness group had less fear of movement compared to the control group - a benefit that was sustained at weeks eight and 12. Patients in the mindfulness group had better quality of life overall and in all three areas than those in the control group at week eight, while at week 12 they continued to report better emotional function. Measurements of fatigue did not vary between the two groups at any time point.

Dr. Karadas noted that participants only reported mild fatigue at the beginning of the study which may explain why meditation did not have any impact.

She said: "Our study shows that mindfulness can reduce fear of movement and improve quality of life in heart attack survivors, with effects extending beyond the completion of the intervention. One explanation may be that meditation replaces catastrophic thinking with positive thoughts, making patients feel less emotionally and physically vulnerable. The findings suggest that mindfulness may be considered in the rehabilitation of patients after a heart attack. These results are very encouraging but more studies are needed to confirm our findings."

Credit: 
European Society of Cardiology

Scientists move closer to developing 'game-changing' test to diagnose Parkinson's

Results published today show it is possible to identify Parkinson's based on compounds found on the surface of skin. The findings offer hope that a pioneering new test could be developed to diagnose the degenerative condition through a simple and painless skin swab.

Scientists at The University of Manchester have developed a technique which works by analysing compounds found in sebum - the oily substance that coats and protects the skin - and identifying changes in people with Parkinson's Disease. Sebum is rich in lipid-like molecules and is one of the lesser studied biological fluids in the diagnosis of the condition. People with Parkinson's may produce more sebum than normal - a condition known as seborrhoea.

The research has been funded by charities Parkinson's UK and the Michael J. Fox Foundation as well as The University of Manchester Innovation Factory. The work was originally funded following an observation by Joy Milne, whose husband was diagnosed with Parkinson's at the age of 45. Working with Dr Tilo Kunath at the University of Edinburgh, Joy demonstrated an incredible ability to distinguish a distinctive Parkinson's odour in individuals using her sense of smell, even before symptoms emerge in those affected.

The team, led by Professor Perdita Barran, The University of Manchester, and the clinical lead Professor Monty Silverdale at Salford Royal Foundation Trust, recruited 500 people with and without Parkinson's. Samples of sebum were taken from their upper backs for analysis. Using different mass spectrometry methods, 10 chemical compounds in sebum were identified which are elevated or reduced in people with Parkinson's. This allows scientists to distinguish people with Parkinson's with 85 per cent accuracy.

The team confirmed their earlier findings published in ACS Central Science that the volatile compounds on skin can be used to diagnose the condition, increasing the number of people sampled and including participants from the Netherlands, as well as the UK.

In a new study published today in Nature Communications, high resolution mass spectrometry was used to profile the complex chemical signature in sebum of people with Parkinson's and show subtle but fundamental changes as the condition progresses. Detailed analysis showed changes in people with Parkinson's in lipid (fat) processing and mitochondria. Problems with mitochondria - the tiny energy-producing batteries that power cells - are one of the hallmarks of Parkinson's.

This means this 'world first' testing strategy is not only useful in diagnosing Parkinson's but also in monitoring the development of the condition. The skin swab could provide an incredibly important new tool in clinical trials helping researchers measure whether new, experimental treatments are able to slow, stop or reverse the progression of Parkinson's.

The study unveiled novel diagnostic sebum-based biomarkers for Parkinson's, provides insight into understanding of how the condition develops, and links lipid dysregulation to altered mitochondrial function.

These promising results published today could lead to a definitive test to diagnose Parkinson's accurately, speedily and cost effectively. The team is now seeking funding to further develop the test and explore the potential for using the test to 'stratify' patients.

Working with the University of Manchester Innovation Factory, the team has patents filed for their diagnostic techniques and are planning to create a spin-out company to commercialise the new tests. They are also working to use this approach to develop tests for COVID-19 as shown in research last week in EClinical Medicine as well as other conditions and are actively seeking investors interested in supporting the drive to bring this technology to market.

Professor Perdita Barran, Professor of Mass Spectrometry at The University of Manchester, said:
"We believe that our results are an extremely encouraging step towards tests that could be used to help diagnose and monitor Parkinson's.

"Not only is the test quick, simple and painless but it should also be extremely cost-effective because it uses existing technology that is already widely available.

"We are now looking to take our findings forwards to refine the test to improve accuracy even further and to take steps towards making this a test that can be used in the NHS and to develop more precise diagnostics and better treatment for this debilitating condition."

Parkinson's tends to develop gradually and it may be many months, even years, before the symptoms become obvious enough for an individual to visit their GP. A DaTscan is regularly used to help specialists confirm the loss of dopamine-producing cells that cause the development of Parkinson's. However, similar loss may also occur in some other rarer neurological conditions. With no molecular test for the condition, diagnosis is made by a neurologist based on a combination of symptoms such as tremor, slowness, stiffness and balance issues. However, many of the symptoms of Parkinson's can overlap with other conditions, especially in the early stages when progression is gradual and symptoms are more subtle.

In a recent survey of more than 2,000 people with Parkinson's carried out by Parkinson's UK, more than a quarter (26 per cent) reported they were misdiagnosed with a different condition before receiving the correct Parkinson's diagnosis.¹

Professor David Dexter, Associate Director of Research at Parkinson's UK, said:

"We are proud to have part-funded this groundbreaking research which marks a significant step towards developing a quick and accurate test that can not only revolutionise the way we diagnose Parkinson's, but also allow us to monitor how this debilitating condition progresses.

"Every hour, two more people in the UK are diagnosed with Parkinson's and a significant portion of these people may well have been misdiagnosed with, and treated for, another condition before receiving their correct diagnosis. This has been compounded in the COVID-19 pandemic where people have been left waiting and have faced months of anxiety to confirm their diagnosis by a health professional. However, with this innovative test, we could see people being diagnosed quickly and accurately enabling them to access vital treatment and support to manage their Parkinson's symptoms sooner."

56-year-old Daxa Kalayci lives in Leicester and was diagnosed with Parkinson's in September 2019. She was misdiagnosed several times over four years before finally finding out she had the condition.

"I was misdiagnosed with anxiety, stress-related tremors and told that my problems stemmed from going through the menopause. I embarked on a 4-month cruise across the globe not knowing I had Parkinson's. Just two weeks into the trip, my symptoms worsened and my dream holiday turned into a nightmare. Without confirmation that it was Parkinson's, which I had suspected for a long time, I was left with unpleasant side-effects caused by different medications prescribed to manage my symptoms.

"Despite my diagnosis eventually being confirmed by a DaTscan, a quick and simple diagnostic test for Parkinson's would have given me the chance to start my treatment earlier and enjoy life a lot more. But instead, I lost so many years not being able to pursue a career as a paramedic or go back to Nursing.

"This test could be a game-changer for people living with Parkinson's and searching for answers like I was. I am so happy with this news because it will mean that in future people won't have to experience the anxiety of multiple appointments, long waiting times and sleepless nights. The sooner this test is available, the better. Anything that can help people looking for a diagnosis is a bonus."

Credit: 
University of Manchester

The world's oldest crater from a meteorite isn't an impact crater after all

Several years after scientists discovered what was considered the oldest crater a meteorite made on the planet, another team found it's actually the result of normal geological processes.

During fieldwork at the Archean Maniitsoq structure in Greenland, an international team of scientists led by the University of Waterloo's Chris Yakymchuk found the features of this region are inconsistent with an impact crater. In 2012, a different team identified it as the remnant of a three-billion-year-old meteorite crater.

"Zircon crystals in the rock are like little time capsules," said Yakymchuk, a professor in Waterloo's Department of Earth and Environmental Sciences. "They preserve ancient damage caused by shockwaves you get from a meteorite impact. We found no such damage in them."

Additionally, there are multiple places where the rocks melted and recrystallized deep in the Earth. This process--called metamorphism--would occur almost instantaneously if produced from an impact. The Waterloo-led team found it happened 40 million years later than the earlier group proposed.

"We went there to explore the area for potential mineral exploration, and it was through close examination of the area and data collected since 2012 that we concluded the features are inconsistent with a meteorite impact," Yakymchuk said. "While we were disappointed that we weren't working in a structure that was the result of a meteorite hitting the planet three billion years ago, science is about advancing knowledge through discovery, and our understanding of the Earth's ancient history continues to evolve. Our findings provide scientific data for resource companies and Greenlandic prospectors to find new mineral resources."

Credit: 
University of Waterloo

Are there differences in the brains of autistic men and women?

Around three times as many males are diagnosed with autism than females. This suggests that biological sex factors may play a role in the development and presentation of autism.

Studies on the neurobiology (brain biology) of males and females with autism have begun to examine brain networks but results have been mixed. This is largely due to the limited availability of data from autistic females.

In response, researchers from Child Mind Institute and colleagues involved in the AIMS2TRIALS, have combined thousands of MRI data openly available for scientific discovery in the Autism Brain Imaging Exchange (ABIDE) repository to explore brain network differences between autistic and neurotypical control males and females. They used the ABIDE sample for discovery of new information and two additional large samples to see if those findings could be repeated (i.e., replicated). These included one sample derived from the Gender Explorations of Neurogenetics and Development to Advance Autism Research made available through the National Database for Autism Research and another one shared by the collaborators of the AIMS2TRIALS.

Across these three samples, the researchers found that both neurotypical males and autistic people showed reduced resting-state brain function in the so-called 'default network', a network that is active when we engage in social cognition or thoughts about ourselves. Additionally, in the discovery sample and in one of the largest of the two replication samples, it was shown that connections between hemispheres (the two halves of the brain) in the visual cortex are reduced in autistic females, while autistic males are not different from males who are not autistic. The results suggest that many autistic people may have different interactions between the two hemispheres of their brain when compared to non-autistic people. This reflects a combination of effects, including some that appear to be unrelated to sex, and some in which there is an interaction between sex and autism diagnosis. Each of these effects appears specific to a different system in the brain.

This study highlights the importance of data sharing and collaboration for implementing discovery science and addressing critical challenges related to reproducibility of findings - which affect all of fields of science. The researchers suggest that there remains an urgent need for more research with similarly large groups of participants, as only then do studies have enough statistical power to reliably account for sources of variability and therefore generate robust conclusions. Until now, limited replication of imaging findings has hampered brain imaging research in autism. The open sharing policies of the Autism Brain Imaging Data Exchange and the NIMH Data Archive, through which the Gender Explorations of Neurogenetics Development to Advance Autism Research was made available, are particularly promising for accelerating the pace of advancement.

Credit: 
The Child Mind Institute

Even short delays in the ER may reduce the lifespan of stroke survivors

DALLAS, March 11, 2021 — For every 10-minute delay between arrival at the emergency room (ER) and starting stroke treatment, patients with severe strokes may lose eight weeks of healthy life, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

Delays between the onset of stroke symptoms and arrival at the hospital have long been known to cost lives and brain cells.

“Our study showed that delays in treatment at the hospital may have even more severe consequences on stroke recovery than pre-hospital arrival delays,” said lead study author Mohammed A. Almekhlafi, M.D., M.Sc., assistant professor of clinical neurosciences, radiology and community health sciences in the Cumming School of Medicine at the University of Calgary in Canada.

To examine the timeliness of in-hospital stroke care, researchers examined the time between ER arrival to the start of mechanical clot-removal treatment among 406 patients who participated in seven international stroke trials (Highly Effective Reperfusion evaluated in Multiple Endovascular Stroke trials - HERMES) comparing mechanical clot retrieval (endovascular thrombectomy) with or without clot-busting medication to clot-busting medication alone. The seven studies were published between 2010 and 2015 with different start and end dates.

The patients had their stroke-causing clots removed at comprehensive stroke centers as participants in one of the seven international clinical trials. All the patients in this sub-analysis had experienced a severe stroke with blockage of one of the large brain arteries, and all were treated within four hours of the time they were last known to be well. Outcomes were calculated in terms of healthy life-years lost, an indicator of quality-of-life after stroke that considers a patients’ life expectancy and the extent of their post-stroke disability.

The researchers found:

The median time between symptom onset and arrival at the ER was just over three hours at 188 minutes.
The median time between ER arrival and an artery being punctured to start the clot-removal procedure was more than an hour-and-a-half at 105 minutes.
Every one-hour delay in the hospital resulted in 11 months of healthy life lost.
Every 10-minute delay in the hospital resulted in eight weeks of healthy life lost.

“I was surprised with the degree to which delays in the hospital impacted stroke outcome even in those who arrived at the hospital early following stroke symptoms,” Almekhlafi said.

After a likely stroke patient arrives at the emergency room of a comprehensive stroke center, they should be evaluated by members of the stroke team and rushed into brain imaging to confirm the stroke diagnosis and identify the site of the blockage in the brain vessels. If eligible, clot-busting medications are administered as quickly as possible. Patients are then rushed to a special operating room for the emergency endovascular therapy.

“Delays could occur if brain scanners or angiography suites are occupied by another patient when the stroke patient arrives, or if there are delays in the notification or arrival of the endovascular team to the hospital (such as during overnight hours or weekends),” Almekhlafi said.

Many national and international professional organizations including the American Stroke Association have suggested benchmarks to monitor the time from emergency room arrival until blood flow is restored to the blocked brain artery in order to reduce the risk of severe disability and death.

“Our findings emphasize the importance of continuously monitoring these time metrics to ensure that the speed of care is optimized,” Almekhlafi said.

A limitation of the study is that all patients were taken directly to a comprehensive stroke center capable of delivering endovascular therapy. There may be different consequences of delays for those who are assessed in the ER at a community hospital and then transferred to another hospital or comprehensive stroke center to receive endovascular therapy.

“Fast, urgent delivery of stroke care is crucial for all stroke patients in order to reduce the risk of death and serious disability,” Almekhlafi said.

Credit: 
American Heart Association

Retinal damage may signal higher risk of stroke, dementia and early death

DALLAS, March 11, 2021 — Pictures of the retina may someday provide early warning signs that a person is at an increased risk of stroke and dementia, making it possible to take preventive measures, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

Studies have shown that people with severe retinopathy, damage to the light-sensing tissue at the back of the eye, are more likely to have a diseased-looking brain on magnetic resonance imaging (MRI).

“The retina is a window to the brain,” said Michelle P. Lin, M.D., M.P.H., lead author of the study and a neurologist at Mayo Clinic Jacksonville in Jacksonville, Florida. “A retinal photo that shows a magnified look at the back of the eye, including the retina and optic nerve, is cheaper and faster to perform than an MRI, so we’re wondering if it might be a good screening tool to see who could benefit from a referral to a neurologist for a brain MRI.”

In addition to the eye doctor’s office, retinal photos could be taken by a smart phone camera or via a smart phone adapter, Lin said.

In this study, researchers examined the association of retinopathy with stroke, dementia, and the risk of death in 5,543 adults (average age of 56 years) who participated in the annual U.S. National Health and Nutrition Examination Surveys (NHANES) between 2005 and 2008. Participants during those years were interviewed about many aspects of their medical history and health behaviors, and in addition, they received a retinal scan photo to look for signs of retinopathy.

Compared with participants not diagnosed with retinopathy, those with retinopathy were:

more than twice as likely to have had a stroke;
almost 70% more likely to have dementia; and
more likely to die within the next 10 years, with each increase in the severity of retinopathy conferring a higher risk of death.

The odds were calculated after adjusting for risk factors including age, high blood pressure, diabetes and if they smoke.

“If you have retinopathy, work closely with your primary care doctor to alter your vascular risk factors and ask to be screened for cognitive impairment. You may be referred to a neurologist for evaluation and possibly a brain MRI,” said Lin, who is also an assistant professor of neurology at the Mayo Clinic College of Medicine.

The study is limited because the NHANES data does not differentiate between various types of stroke. In addition, because the surveys rely on self-reported memory problems as an indicator of dementia, the occurrence of dementia may be overestimated.

Credit: 
American Heart Association

African American women experience higher risk of pregnancy-related stroke, death

DALLAS, March 11, 2021 -- African American women have a significantly increased risk of stroke and death during pregnancy and childbirth or in the period right after birth, compared to the risk of stroke among white women, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

"Each year, thousands of American women have a stroke or die from a stroke during pregnancy. The risk of stroke is also high following childbirth," said lead study author Mohamed M. Gad, M.D., a resident physician in the department of internal medicine at the Cleveland Clinic in Cleveland, Ohio. "Even so, we lack data on the racial disparities in cardiovascular disease and stroke outcomes for women during and post-pregnancy in the U.S."

Using the Nationwide Inpatient Sample, a hospital database across the U.S., researchers analyzed data on nearly 40 million pregnant and post-partum women hospitalized during pregnancy regardless of cause between 2002 and 2017. Nearly 22% of the women included were African American.

Researchers evaluated stroke outcomes among the pregnant women and found:

While pregnancy-related stroke was very rare, occurring in just 0.03% of the overall study population, 41% of the women who experienced a stroke during pregnancy were African American.

The highest number of in-hospital deaths for women with pregnancy-associated stroke occurred among African American women, 7.8% versus 5% for white women.

Compared with white women, African American women with pregnancy-associated stroke faced nearly two times the risk of dying from stroke, and the increased risk of death was consistent across age groups. There was little change in these results after accounting for multiple risk factors.

When comparing pregnancy-associated stroke outcomes by income levels, African American women in the lowest income group were 1.91 times more likely to die than white women in the same income group. In the highest income group, African American women were 2.38 times more likely to die compared to their white counterparts.

"We found that serious disparities exist despite adjusting for socioeconomic variables. This means that there is no single socioeconomic factor such as income or access to health care that puts a woman more at-risk. Those factors can contribute, yet they do not explain the whole story," Gad said. "We need to understand and address other potential causes of pregnancy-associated stroke and death. If addressed, we can lower the overall burden of disease in the U.S."

Gad said the study provides evidence that can help improve understanding and guide interventions that could help minimize these racial gaps.

Credit: 
American Heart Association